AHACHumacyte, Inc.

Nasdaq humacyte.com


$ 5.03 $ 0.09 (1.72 %)    

Wednesday, 26-Jun-2024 10:15:31 EDT
QQQ $ 480.29 $ 0.69 (0.14 %)
DIA $ 389.40 $ -0.71 (-0.18 %)
SPY $ 544.52 $ 0.92 (0.17 %)
TLT $ 93.42 $ -0.14 (-0.15 %)
GLD $ 212.60 $ -1.60 (-0.74 %)
$ 4.93
$ 4.95
$ 0.00 x 0
$ 0.00 x 0
$ 4.86 - $ 5.05
$ 1.96 - $ 9.97
3,169,946
na
533.65M
$ 1.54
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 03-28-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 05-12-2023 03-31-2023 10-Q
6 03-24-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-12-2022 06-30-2022 10-Q
9 05-13-2022 03-31-2022 10-Q
10 03-29-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 05-17-2021 03-31-2021 10-Q
14 02-16-2021 12-31-2020 10-K
15 11-13-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 the-past-weeks-notable-insider-buys-callon-petroleum-cricut-krispy-kreme-and-more

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Some...

 alpha-healthcare-acquisition-announces-shareholder-approval-of-business-combination-with-humacyte

Alpha Healthcare Acquisition Corp. (NASDAQ:AHAC) ("AHAC"), a special purpose acquisition company, today announced that ...

Core News & Articles

    Thursday morning, 173 companies reached new 52-week lows.

 benchmark-initiates-coverage-on-alpha-healthcare-with-buy-rating-announces-price-target-of-18

Benchmark analyst Bruce Jackson initiates coverage on Alpha Healthcare (NASDAQ:AHAC) with a Buy rating and announces Price T...

 alpha-healthcare-acquisition-corp-spac-merger-partner-humacyte-reports-expansion-of-strategic-global-partnership-with-fresenius-medical-care

Partnership expanded to include vascular trauma repair outside of the United States. Fresenius Medical Care will adopt the H...

 humacyte-ceo-dr-laura-niklason-says-vascular-trauma-trial-is-still-underway-anticipates-filing-bla-application-sometime-in-2022-if-this-were-case-would-expect-first-approval-sometime-in-2023

https://www.youtube.com/watch?v=8lbZJjeH2MA

 humacyte-ceo-dr-laura-niklason-says-co-has-phase-3-trials-underway-for-vascular-trauma-and-kidney-failure-says-these-are-first-two-conditions-co-anticipates-gaining-approval-for

https://www.youtube.com/watch?v=8lbZJjeH2MA

 alpha-healthcare-ceo-rajiv-shukla-says-humacyte-stood-out-cites-extensive-pipeline-and-large-market-opportunities-says-investment-thesis-is-to-find-companies-with-large-addressable-market-and-lead-in-that-market

https://www.youtube.com/watch?v=8lbZJjeH2MA

 humacyte-ceo-dr-laura-niklason-said-considered-spac-and-ipo-pathways-says-spac-decision-was-due-to-experienced-organization-at-alpha-says-spac-route-also-allows-co-to-interact-closely-with-investors

https://www.youtube.com/watch?v=8lbZJjeH2MA

 alpha-healthcare-acquisition-ma-partner-humacyte-announces-long-term-follow-up-data-from-phase-2-vascular-access-trial

Five-year outcomes demonstrate HAV retained durability and structural integrity, potentially offering a safe and viable optio...

 the-boiler-room-stock-pitch-recap-northern-star-acquisition-mogo-wisekey-autozone-and-more

Every Friday, at 3 p.m. ET, Ritholtz Wealth Management CEO Josh Brown and Benzinga CEO Jason Raznick host "The Boiler Room,...

 lake-street-initiates-coverage-on-alpha-healthcare-with-buy-rating-announces-price-target-of-20

Lake Street analyst Brooks O'Neil initiates coverage on Alpha Healthcare (NASDAQ:AHAC) with a Buy rating and announces P...

 the-boiler-room-stock-pitch-recap-futu-intuitive-surgical-ocugen-sprouts-farmers-market-and-more

Every Friday, at 3 p.m. ET, Ritholtz Wealth Management CEO Josh Brown and Benzinga CEO Jason Raznick host "The Boiler Room,...

 40-stocks-moving-in-thursdays-pre-market-session

Gainers AmeriServ Financial, Inc. (NASDAQ: ASRV) rose 199.3% to $12.30 in pre-market trading.

Core News & Articles

    During Monday's morning trading, 285 companies set new 52-week highs.

 spacs-attack-weekly-recap-8-deals-new-spacs-to-watch-and-headline-news

The four-day trading week saw no weakness in SPAC deal announcements or headlines, all of which we followed on Benzinga's S...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION